Design Therapeutics, Inc. DSGN Depreciation
Depreciation at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s depreciation?
- Design Therapeutics, Inc. (DSGN) reported depreciation of $157K in Q1 2026.
- How has Design Therapeutics, Inc.'s depreciation changed year-over-year?
- Design Therapeutics, Inc.'s depreciation decreased by 1.3% year-over-year, from $159K to $157K.
- What is the long-term trend for Design Therapeutics, Inc.'s depreciation?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s depreciation has grown at a 48.2% compound annual growth rate (CAGR), from $129K to $622K.